AbbVie Will Launch CLL Campaign at Cabrillo National Monument

The campaign will encourage outdoor activities for chronic lymphocytic leukemia patients with an inaugural walk on October 17, 2026.

Updated on Oct. 14, 2026 in Cancer

AbbVie Will Launch CLL Campaign at Cabrillo National Monument

Live Poll

Do you trust pharmaceutical-sponsored lifestyle programs to prioritize patient well-being over corporate interests?

AbbVie, the National Park Foundation, and the CLL Society will debut the Time For Treks campaign on October 17, 2026. This initiative promotes outdoor connection for those living with chronic lymphocytic leukemia, starting with a community walk at San Diego’s Cabrillo National Monument.

Why it matters

The campaign addresses findings from a 2024 survey regarding the emotional impact of a CLL diagnosis. By prioritizing patient-identified interests like hiking, the initiative aims to foster community connections and support for those navigating the condition.

AbbVie released a 2024 survey detailing the emotional toll of a CLL diagnosis to guide patient support efforts. The initiative builds upon the market entry of Venclexta in 2016 and the initial 2013 regulatory approval of Imbruvica.

The players

AbbVie

This research-based global biopharmaceutical company focuses on developing advanced therapies for complex and chronic diseases.

National Park Foundation

This is the official nonprofit partner of the National Park Service that works to protect and enhance America's national parks.

CLL Society

This patient-centric organization provides support, education, and advocacy for individuals living with chronic lymphocytic leukemia.

The details

Co-created with patients, the campaign will utilize AbbVie's existing CLL educational website to encourage outdoor participation. The launch follows the 2025 release of the Second Winds film, which spotlighted the personal experiences of patients named Alejandro, Christina, and Jeff.

Imbruvica received initial regulatory approval in 2013.
Venclexta first hit the market in 2016.
AbbVie conducted a survey on CLL diagnosis impacts in 2024.
AbbVie released the Second Winds short film in 2025.
The campaign launch and community walk will occur on October 17, 2026.

The Big Picture

This effort follows the CLL Society support programs model, which seeks to integrate patient wellness beyond clinical treatments. It signifies a shift toward prioritizing holistic lifestyle experiences as a formal component of managing chronic leukemia diagnoses.

Local patients and their families can participate in the inaugural community walk at Cabrillo National Monument to engage with support networks. The campaign offers those living with CLL new avenues to prioritize physical activity and social interaction as part of their health journey.

The takeaway

Engaging in outdoor physical activity can provide meaningful emotional benefits for those living with chronic conditions. Patients are encouraged to explore how local nature-based initiatives can complement their existing health routines.